Teva Pharmaceutical Industries

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TEVA and other ETFs, options, and stocks.

About TEVA

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets.

CEO

Richard Francis

CEORichard Francis

Employees

33,346

Employees33,346

Headquarters

Tel Aviv, Tel Aviv

HeadquartersTel Aviv, Tel Aviv

Founded

1901

Founded1901

Employees

33,346

Employees33,346

TEVA Key Statistics

Market cap

49.48B

Market cap49.48B

Price-Earnings ratio

98.38

Price-Earnings ratio98.38

Dividend yield

—

Dividend yield—

Average volume

8.09M

Average volume8.09M

High today

$42.58

High today$42.58

Low today

$41.41

Low today$41.41

Open price

$41.45

Open price$41.45

Volume

2.68M

Volume2.68M

52 Week high

$43.34

52 Week high$43.34

52 Week low

$16.74

52 Week low$16.74

Stock Snapshot

Teva Pharmaceutical Industries(TEVA) stock is priced at $42.46, giving the company a market capitalization of 49.48B. It carries a P/E multiple of 98.38.

On 2026-11-06, Teva Pharmaceutical Industries(TEVA) stock moved within a range of $41.41 to $42.58. With shares now at $42.46, the stock is trading +2.5% above its intraday low and -0.3% below the session's peak.

Trading activity shows a volume of 2.68M, compared to an average daily volume of 8.09M.

Over the past 52 weeks, Teva Pharmaceutical Industries(TEVA) stock has traded between a high of $43.34 and a low of $16.74.

TEVA News

The Motley Fool 5h

Teva's 3 Key Branded Drugs Grew Sales 33% Last Quarter. Is This Turnaround Stock a Buy Right Now? - The Motley Fool

...

Simply Wall St 1d

Learn Why The Bull Case For Teva Pharmaceutical Industries Could Change Following Raised Revenue Guidance

Teva Pharmaceutical Industries reported Q3 2026 sales of US$4.4b with earnings above analyst estimates, raised its 2026 revenue outlook to a range of US$16.7b t...

Zacks 3d

Compared to Estimates, Teva Pharmaceutical Industries Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2026, Teva Pharmaceutical Industries Ltd. (TEVA Quick QuoteTEVA - Free Report) reported revenue of $4.4 billion, down 1.9%...

Analyst ratings

88%

of 16 ratings

Buy

87.5%

Hold

12.5%

Sell

More TEVA News

Simply Wall St 3d

Teva Pharmaceutical Industries Dropped, So What Is Behind The Latest Attention?

Teva Pharmaceutical Industries (NYSE:TEVA) has halted its Phase 2 TOPAS-MSA trial for emrusolmin after an interim futility analysis indicated a low chance of hi...

People also own

Based on the portfolios of people who own TEVA. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.